Chemotherapy & More
- This forum has 1,151 topics, 3,414 replies, and was last updated 2 years ago by
.
-
- Topic
- Voices
- Posts
- Last Post
-
- Clinical outcomes for hilar and extrahepatic cholangiocarcinoma with adjuvant, d
- 1
- 1
- 2 years, 8 months ago
- [Impact of adjuvant chemotherapy on prognosis in intrahepatic cholangiocarcinoma
- 1
- 1
- 2 years, 8 months ago
- Paclitaxel Restores Sensitivity to Chemotherapy in Preclinical Models of Multidr
- 1
- 1
- 2 years, 8 months ago
- DWI-based radiomic signature: potential role for individualized adjuvant chemoth
- 1
- 1
- 2 years, 8 months ago
- Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcino
- 1
- 1
- 2 years, 9 months ago
- Individual patient data meta-analysis of adjuvant gemcitabine-based chemotherapy
- 1
- 1
- 2 years, 9 months ago
- Penpulimab, an anti-PD1 IgG1 antibody in the treatment of advanced or metastatic
- 1
- 1
- 2 years, 9 months ago
- Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract canc
- 1
- 1
- 2 years, 9 months ago
- Outcomes in patients receiving palliative chemotherapy for advanced biliary trac
- 1
- 1
- 2 years, 9 months ago
- Partial treatment response to capmatinib in MET-amplified metastatic intrahepati
- 1
- 1
- 2 years, 9 months ago
- Chemoresistance and resistance to targeted therapies in biliary tract cancer: Wh
- 1
- 1
- 2 years, 9 months ago
- Phase II study of combination pembrolizumab and olaparib in patients with advanc
- 1
- 1
- 2 years, 10 months ago
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.